PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Marselli, L.* ; Piron, A.* ; Suleiman, M.* ; Colli, M.L.* ; Yi, X.* ; Khamis, A.* ; Carrat, G.R.* ; Rutter, G.A.* ; Bugliani, M.* ; Giusti, L.* ; Ronci, M.* ; Ibberson, M.* ; Turatsinze, J.V.* ; Boggi, U.* ; De Simone, P.* ; De Tata, V.* ; Lopes, M.* ; Nasteska, D.* ; De Luca, C.* ; Tesi, M.* ; Bosi, E.* ; Singh, P.* ; Campani, D.* ; Schulte, A.M.* ; Solimena, M. ; Hecht, P.* ; Rady, B.* ; Bakaj, I.* ; Pocai, A.* ; Norquay, L.* ; Thorens, B.* ; Canouil, M.* ; Froguel, P.* ; Eizirik, D.L.* ; Cnop, M.* ; Marchetti, P.*

Persistent or transient human β cell dysfunction induced by metabolic stress: Specific signatures and shared gene expression with type 2 diabetes.

Cell Rep. 33:108466 (2020)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whether human β cell dysfunction induced by metabolic stress is reversible, evaluate the molecular pathways underlying persistent or transient damage, and explore the relationships with T2D islet traits. Twenty-six islet preparations are exposed to several lipotoxic/glucotoxic conditions, some of which impair insulin release, depending on stressor type, concentration, and combination. The reversal of dysfunction occurs after washout for some, although not all, of the lipoglucotoxic insults. Islet transcriptomes assessed by RNA sequencing and expression quantitative trait loci (eQTL) analysis identify specific pathways underlying β cell failure and recovery. Comparison of a large number of human T2D islet transcriptomes with those of persistent or reversible β cell lipoglucotoxicity show shared gene expression signatures. The identification of mechanisms associated with human β cell dysfunction and recovery and their overlap with T2D islet traits provide insights into T2D pathogenesis, fostering the development of improved β cell-targeted therapeutic strategies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.109
1.707
21
20
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Beta Cells ; Damage ; Endoplasmic Reticulum Stress ; Eqtl ; Glucolipotoxicity ; Human Pancreatic Islets ; Lipoglucotoxicity ; Recovery ; Transcriptome ; Type 2 Diabetes
Sprache englisch
Veröffentlichungsjahr 2020
HGF-Berichtsjahr 2020
ISSN (print) / ISBN 2211-1247
e-ISSN 2211-1247
Zeitschrift Cell Reports
Quellenangaben Band: 33, Heft: 9, Seiten: , Artikelnummer: 108466 Supplement: ,
Verlag Cell Press
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Pancreatic Islet Research (IPI)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502600-001
Förderungen Wellcome Investigator Award
Leona M. and Harry B. Helmsley Charitable Trust
JDRF
EFPIA
Union's Horizon 2020 research and innovation programme
Innovative Medicines Initiative 2 Joint Undertaking
Swiss State Secretariat for Education, Research, and Innovation (SERI)
European Union's Horizon 2020 research and innovation programme, EFPIA
Innovative Medicines Initiative 2 Joint Undertaking Rhapsody
European Union's Horizon 2020 research and innovation programme, project T2DSystems
Italian Ministry of University and Research (PRIN 2017)
MRC (UK) Programme grant
Agence Nationale de la Recherche (ANR EQUIPEX Ligan), France
Agence Nationale de la Recherche, France
Societe Francophone du Diabete
Centre National de la Recherche Scientifique
Brussels Region Innoviris project DiaType, Belgium
Welbio
Fonds National de la Recherche Scientifique (FNRS)
Janssen Research & Development, Philadelphia, PA
DOI 10.1016/j.celrep.2020.108466
WOS ID WOS:000595658100021
Scopus ID 85097044240
PubMed ID 33264613
Erfassungsdatum 2020-12-20
[➜Korrektur melden]